{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:55:22Z","timestamp":1789152922228,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023Y0020"],"award-info":[{"award-number":["2023Y0020"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.breast.2025.104543","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T06:44:12Z","timestamp":1752734652000},"page":"104543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of a machine learning prediction model on the false-negative rate of sentinel lymph node biopsy for clinically node-positive breast cancer after neoadjuvant chemotherapy"],"prefix":"10.1016","volume":"83","author":[{"given":"Minyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangwei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2025.104543_bib1","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/cncr.29348","article-title":"Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States","volume":"121","author":"Mougalian","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2025.104543_bib2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2025.104543_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000658-199907000-00011","article-title":"Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy","volume":"230","author":"Kuerer","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2025.104543_bib6","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1200\/JCO.2005.07.032","article-title":"Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer","volume":"23","author":"Buzdar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib7","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1200\/JCO.2005.02.5023","article-title":"Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy","volume":"23","author":"Hennessy","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib8","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2025.104543_bib9","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2025.104543_bib10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2025.104543_bib13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib14","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1245\/s10434-019-07809-7","article-title":"Axillary lymph node ultrasound following neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: results from the SN FNAC study","volume":"26","author":"Morency","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ultrasmedbio.2018.10.026","article-title":"Axillary pathologic complete response to neoadjuvant chemotherapy in clinically node-positive breast cancer patients: a predictive model integrating the imaging characteristics of ultrasound restaging with known clinicopathologic characteristics","volume":"45","author":"Kim","year":"2019","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.breast.2025.104543_bib16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2214\/AJR.17.18295","article-title":"Axillary ultrasound identifies residual nodal disease after chemotherapy: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance)","volume":"210","author":"Le-Petross","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.breast.2025.104543_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2025.104543_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12885-022-10496-5","article-title":"A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2025.104543_bib19","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","article-title":"A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy","volume":"10","author":"Van Zee","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-004-5781-z","article-title":"An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement","volume":"91","author":"Barranger","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2025.104543_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2407-8-66","article-title":"New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients","volume":"8","author":"Kohrt","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2025.104543_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1245\/ASO.2003.05.020","article-title":"Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer","volume":"10","author":"Hwang","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/bjs.5943","article-title":"A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive","volume":"95","author":"Pal","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.breast.2025.104543_bib24","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1245\/s10434-018-6345-5","article-title":"A predictive model for axillary node pathologic complete response after neoadjuvant chemotherapy for breast cancer","volume":"25","author":"Kantor","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10549-012-2109-2","article-title":"Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique","volume":"134","author":"Takada","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2025.104543_bib26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/bjc.2016.444","article-title":"Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy","volume":"116","author":"Fujii","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2025.104543_bib27","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1245\/s10434-019-07655-7","article-title":"A nomogram to predict the pathologic complete response of neoadjuvant chemotherapy in triple-negative breast cancer based on simple laboratory indicators","volume":"26","author":"Zhang","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib28","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/ajg.2013.332","article-title":"Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma","volume":"108","author":"Singal","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.breast.2025.104543_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.577537","article-title":"Machine learning algorithms for the prediction of central lymph node metastasis in patients with papillary thyroid cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.breast.2025.104543_bib30","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2025.104543_bib31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/SLA.0000000000004356","article-title":"Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a systematic review and meta-analysis","volume":"273","author":"Samiei","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2025.104543_bib32","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American college of surgeons oncology group Z1071 trial (alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib33","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jamcollsurg.2019.01.022","article-title":"Value of axillary ultrasound after negative axillary MRI for evaluating nodal status in high-risk breast cancer","volume":"228","author":"Almerey","year":"2019","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.breast.2025.104543_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10549-013-2691-y","volume":"142","author":"Ohno","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2025.104543_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4048\/jbc.2015.18.1.16","article-title":"Predictive significance of p53, Ki-67, and Bcl-2 expression for pathologic complete response after neoadjuvant chemotherapy for triple-negative breast cancer","volume":"18","author":"Kim","year":"2015","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.breast.2025.104543_bib36","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3892\/mco.2015.579","article-title":"Predictors of pathological complete response to neoadjuvant chemotherapy in stage II and III breast cancer: the impact of chemotherapeutic regimen","volume":"3","author":"Nwaogu","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13277-012-0513-1","article-title":"Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy","volume":"34","author":"Stoetzer","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.breast.2025.104543_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2025.104543_bib39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiol.2019190014","article-title":"Predicting axillary response to neoadjuvant chemotherapy: breast MRI and US in patients with node-positive breast cancer","volume":"293","author":"Kim","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2025.104543_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.581321","article-title":"Predicting axillary lymph node status with a nomogram based on breast lesion ultrasound features: performance in N1 breast cancer patients","volume":"10","author":"Luo","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib41","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ultrasmedbio.2017.05.003","article-title":"Axillary lymph node sonographic features and breast tumor characteristics as predictors of malignancy: a nomogram to predict risk","volume":"43","author":"de Camargo Teixeira","year":"2017","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.breast.2025.104543_bib42","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","article-title":"The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer","volume":"19","author":"Alvarado","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib43","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1245\/s10434-013-2902-0","article-title":"Early assessment of axillary response with 18F-FDG PET\/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla","volume":"20","author":"Koolen","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib44","doi-asserted-by":"crossref","first-page":"79147","DOI":"10.18632\/oncotarget.16131","article-title":"Predicting level 2 axillary lymph node metastasis in a Chinese breast cancer population post-neoadjuvant chemotherapy: development and assessment of a new predictive nomogram","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.breast.2025.104543_bib45","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ejso.2016.05.039","article-title":"Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: a single-institution retrospective study","volume":"42","author":"Zhang","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2025.104543_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/000313481508100918","article-title":"Comparison between ultrasound and pathologic status of axillary lymph nodes in clinically node-negative breast cancer patients","volume":"81","author":"Bailey","year":"2015","journal-title":"Am Surg"},{"key":"10.1016\/j.breast.2025.104543_bib47","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ultrasmedbio.2017.09.020","article-title":"Correlation between ultrasound appearance of small breast cancer and axillary lymph node metastasis","volume":"44","author":"Yu","year":"2018","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.breast.2025.104543_bib48","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3390\/cancers13071539","article-title":"The evolving role of marked lymph node biopsy (MLNB) and targeted axillary dissection (TAD) after neoadjuvant chemotherapy (NACT) for node-positive breast cancer: systematic review and pooled analysis","volume":"13","author":"Swarnkar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.breast.2025.104543_bib49","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10549-022-06707-z","article-title":"Improved false-negative rates using a novel patient selection flowchart in initially biopsy-proven node-positive breast cancer undergoing blue-dye alone guided sentinel lymph node biopsy after neoadjuvant chemotherapy","volume":"196","author":"Chen","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2025.104543_bib50","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(95)91746-2","article-title":"Introduction to neural networks","volume":"346","author":"Cross","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2025.104543_bib51","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/07853899509002462","article-title":"Artificial neural networks for decision support in clinical medicine","volume":"27","author":"Forsstr\u00f6m","year":"1995","journal-title":"Ann Med"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625005600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625005600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:05:02Z","timestamp":1772773502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625005600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":51,"alternative-id":["S0960977625005600"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104543","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of a machine learning prediction model on the false-negative rate of sentinel lymph node biopsy for clinically node-positive breast cancer after neoadjuvant chemotherapy","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104543"}}